S X Gu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

S X Gu

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Journal of Thrombosis and Haemostasis : JTH|July 9, 2018

Targeting platelet EPCR for better therapeutic factor VIIa activityS X Gu, S R Lentz

Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1997

[Study on the synthesis and antibacterial activity of Mannich bases containing alpha, beta-unsaturated ketone]S X Gu, K L Yao, Y H Gu

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 1, 1988

[Histamine and lung cancer. II. Human lung cancer cell line and histamine]L F Xue, J Cheng, J W Wang, et al.

The British Journal of Dermatology|July 8, 2018

A Chinese herbal medicine preparation (Pei Tu Qing Xin) for children with moderate-to-severe atopic eczema: a pilot randomized controlled trialS X Gu, X Mo, A L Zhang, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Journal of Thrombosis and Haemostasis : JTH|July 9, 2018

Targeting platelet EPCR for better therapeutic factor VIIa activityS X Gu, S R Lentz

Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1997

[Study on the synthesis and antibacterial activity of Mannich bases containing alpha, beta-unsaturated ketone]S X Gu, K L Yao, Y H Gu

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 1, 1988

[Histamine and lung cancer. II. Human lung cancer cell line and histamine]L F Xue, J Cheng, J W Wang, et al.

The British Journal of Dermatology|July 8, 2018

A Chinese herbal medicine preparation (Pei Tu Qing Xin) for children with moderate-to-severe atopic eczema: a pilot randomized controlled trialS X Gu, X Mo, A L Zhang, et al.

Pageof 1